Atlas Trials

A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia

Clinical trial NCT01350947 · COMPLETED

Trial details

NCT number
NCT01350947
Sponsor
University of Utah
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Myelomonocytic Leukemia
Start date
2011-04-01
Primary completion
2014-09-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.